JO
CAMP icon

John Overdeck’s CAMP4 Therapeutics CAMP Stock Holding History

John Overdeck’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$457K Sell
104,610
-4,265
-4% -$18.4K ﹤0.01% 4217
2026
Q1 		$480K Buy
108,875
+14,344
+15% +$68.1K ﹤0.01% 3767
2025
Q4 		$579K Sell
94,531
-2,840
-3% -$12.1K ﹤0.01% 3227
2025
Q3 		$292K Buy
+97,371
New +$180K ﹤0.01% 3221

Other funds holding CAMP

JT
Jupiter Topco New York $245B AUM
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

John Overdeck's CAMP Position: Q2 2026 in Review

John Overdeck reduced its CAMP4 Therapeutics (CAMP) stake by 3.9% in Q2 2026, selling an estimated $18.4K and leaving 104,610 shares worth $457K. The position accounts for ﹤0.01% of the portfolio, ranked #4217.

John Overdeck first reported a position in CAMP in Q3 2025 and has held it in 4 quarters since. The position peaked at $579K in Q4 2025. 61 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

  • John Overdeck held 104,610 shares of CAMP4 Therapeutics worth $457K as of Q2 2026.
  • John Overdeck sold 4,265 CAMP4 Therapeutics shares in Q2 2026, an estimated $18.4K.
  • CAMP4 Therapeutics made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4217 holding.
  • John Overdeck first reported a position in CAMP4 Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • John Overdeck's CAMP4 Therapeutics position peaked at $579K in Q4 2025.
  • 61 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.